Evgen Pharma's total assets for Q4 2023 were £3.06M, a decrease of -29.61% from the previous quarter. GB:TCF total liabilities were £721.00K for the fiscal quarter, a 73.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.